About Us

Vision & Mission

To improve the healthcare journey and outcomes for individuals with complex, chronic diseases through innovative and actionable precision medicine testing solutions for immune-mediated inflammatory diseases.

We empower healthcare specialists with the ability to accelerate the achievement of sustained disease remission and disease control. Our precision-guided testing services enable clinicians to achieve improved outcomes, while supporting payer objectives of cost-effective care.

LEADERSHIP TEAM

Patricia Vasquez

President

Patricia Vasquez, President, previously held the role of Senior Vice President, Commercial and Corporate Development for the company. Prior to that, she served as Vice President, Global Marketing, Business Development and Service at Werfen, where led the successful global launch of systems and novel tests for immune-mediated diseases, established key technology and biomarker partnerships. Patricia was a founding executive of Proprius Pharmaceuticals (sold to Cypress Biosciences) where, as Vice President, Marketing and Corporate Development, she in-licensed precision medicine and therapeutic assets, and launched the Avise precision medicine services in rheumatology. Patricia holds a BA in Industrial/Organizational Psychology and an MBA from San Diego State University.

Thierry Dervieux PharmD, PhD

Chief Scientific Officer

Thierry Dervieux, PharmD, PhD, Chief Scientific Officer, was most recently Chief Scientific Officer at Exagen Diagnostics, where he spent a decade building the Avise® portfolio of testing solutions. Prior to Exagen, Thierry was a founding executive of Proprius Pharmaceuticals (sold to Cypress Biosciences), where he started to develop a portfolio of precision guided dosing solutions for the management of AI gastrointestinal and rheumatic diseases. He is certified by the American Board of Clinical Chemistry in Clinical Chemistry and Molecular Diagnostics and holds PharmD and PhD degrees from Claude Bernard University. Thierry is the inventor or co-inventor on several patents and patent applications and has authored or co-authored over 70 publications.

Brian Littlefield

Senior Vice President of Information Services

Brian Littlefield, Senior Vice President of Information Services. Previously, Brian served at Exagen Diagnostics, where he established the IS function, and developed and implemented information systems that enabled the company’s rapid growth. Prior to Exagen, Brian was with Prometheus Laboratories in a similar role, having joined just following the formation of the company. During that time, he led and developed specialized systems to support proprietary diagnostics testing services and promotion of specialty therapeutics. Prior to that, Brian worked as a consultant with Deloitte, and as Director of Support Services at Quidel Corporation. He holds a BS in Biochemistry from Purdue University, and an MBA from Pepperdine University.

Claudia Ibarra

Senior Vice President, Technical Operations

Claudia Ibarra, Senior Vice President, Technical Operations, was most recently Chief Operating Officer at DermTech, where she led a dynamic team of scientists, customer service, supply chain and facilities professionals. Before joining DermTech Claudia served as Senior Vice President, Laboratory Operations at Exagen. Prior to Exagen, she was the Director of the molecular oncology laboratory at Genoptix, Inc., where she validated and implemented new molecular technology and diagnostic assays. Claudia holds a degree in Biochemistry with specialization in Clinical Laboratory Science from the University of Buenos Aires, Argentina and a California License as Clinical Laboratory Scientist.

Daniel Gonzalez

Senior Vice President of Finance and Accounting

Daniel Gonzalez, Senior Vice President of Finance and Accounting, has extensive experience leading finance functions across high-growth biotechnology and life sciences companies. Prior to joining the team, Daniel provided consulting services to therapeutics companies, supporting business development, corporate finance and tender offers. Previously, Daniel was Senior Vice President of Finance and Business Development at Huyabio International, where he expanded the finance function, led fundraising efforts and negotiated deal structures with global pharmaceutical companies. Daniel brings experience in leading the finance function in a molecular diagnostics lab setting from his role as Vice President of Finance at Progenity Inc., where he built and scaled the team, launched new business lines and played a key role in preparing the company for its IPO. Daniel holds a degree from the University of California, San Diego, and an MBA from the Drucker School of Management at Claremont Graduate University.

Patricia Vasquez, President, Commercial and Corporate Development, most recently served as Vice President, Global Marketing, Business Development…

Thierry Dervieux, PharmD, PhD, Chief Scientific Officer, was most recently Chief Scientific Officer at Exagen Diagnostics, where he spent a decade building the Avise® portfolio of testing solutions…

Brian Littlefield, Senior Vice President of Information Services. Previously, Brian served at Exagen Diagnostics, where he established the IS function, and developed…

Claudia Ibarra, Senior Vice President, Technical Operations, was most recently Chief Operating Officer at DermTech, where she led a dynamic team of scientists, customer…

Daniel Gonzalez, Senior Vice President of Finance and Accounting, has extensive experience leading finance functions across high-growth biotechnology and life sciences…

BOARD OF DIRECTORS

Michael Walsh, Chairman, most recently served as a Board Member for Lineagen, which provided specialized genetic testing for children with…

Scott Glenn is Managing Partner of Windamere Venture Partners and Chairman of ReBalance Health. He founded and sold, or took public…

Rolf Benirschke is CEO of Legacy Health Strategies, a patient engagement company, and founder of The Grateful Patient Project. As a former NFL placekicker…

Scientific Advisors

Stephen B. Hanauer, MD, FACG, is an internationally recognized expert on the treatment of inflammatory bowel disease (IBD) and an advisor on the development of multiple leading IBD drugs. He is a board-certified internist and gastroenterologist…

Dr. McGovern is a gastroenterologist and preeminent geneticist in the IBD field. Dr. McGovern completed his GI fellowship and obtained a PhD in complex disease genetics at the University of Oxford, England before moving to Cedars-Sinai …

Marla C Dubinsky is a Professor of Pediatrics and Medicine at the Icahn School of Medicine at Mount Sinai, New York, NY. Dr. Dubinsky received her medical degree from Queen’s University, Canada. She completed her pediatric residency at…

Adam S. Cheifetz is the Director of the Center for Inflammatory Bowel Disease and Medical Director of Infusion Services at Beth Israel Deaconess Medical Center and Professor of Medicine at Harvard Medical School. He is also Director of the Harvard Medical School Gastroenterology…

Bincy P. Abraham is the Distinguished Professor and Director of the Fondren Inflammatory Bowel Disease Program at the Underwood Digestive Diseases Center of Houston Methodist Hospital…

About Us

Vision & Mission

Patricia Vasquez

Thierry Dervieux, PharmD, PhD

Brian Littlefied

Claudia Ibarra

Daniel Gonzalez

Michael Walsh

Scott Glenn

Rolf Benirschke

Stephen B. Hanauer, MD, FACG

Dermot McGovern, MD, PhD

Marla C Dubinsky, MD

Adam Cheifetz, MD

Bincy P. Abraham, MD, MS, AGAF, FACG, FASGE